Merck & Co. and Eisai Report Keytruda Plus Lenvima Study in Endometrial CancerBy topmanagerDecember 8, 20230 Merck & Co. and Eisai recently announced the outcome of a Phase 3 study investigating the use of Keytruda plus…
